These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35301148)

  • 1. Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods.
    Choudhury C; Arul Murugan N; Priyakumar UD
    Drug Discov Today; 2022 Jul; 27(7):1847-1861. PubMed ID: 35301148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of artificial intelligence and machine learning in drug repurposing.
    Ghandikota SK; Jegga AG
    Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence in COVID-19 drug repurposing.
    Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
    Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.
    Cong Y; Endo T
    OMICS; 2022 Jul; 26(7):361-371. PubMed ID: 35759424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19.
    Ahmed F; Soomro AM; Chethikkattuveli Salih AR; Samantasinghar A; Asif A; Kang IS; Choi KH
    Biomed Pharmacother; 2022 Sep; 153():113350. PubMed ID: 35777222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence, machine learning, and drug repurposing in cancer.
    Tanoli Z; Vähä-Koskela M; Aittokallio T
    Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent omics-based computational methods for COVID-19 drug discovery and repurposing.
    Tayara H; Abdelbaky I; To Chong K
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34423353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
    Muller C; Rabal O; Diaz Gonzalez C
    Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning Applications in Drug Repurposing.
    Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
    Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
    Ng YL; Salim CK; Chu JJH
    Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting COVID-19 with Artificial Intelligence.
    Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
    Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerating COVID-19 Drug Discovery with High-Performance Computing.
    Heifetz A
    Methods Mol Biol; 2024; 2716():405-411. PubMed ID: 37702951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
    Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
    Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review.
    Kaushal K; Sarma P; Rana SV; Medhi B; Naithani M
    J Biomol Struct Dyn; 2022 Jul; 40(10):4750-4765. PubMed ID: 33300456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential applications of artificial intelligence in drug discovery and development.
    Farghali H; Kutinová Canová N; Arora M
    Physiol Res; 2021 Dec; 70(Suppl4):S715-S722. PubMed ID: 35199553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern computational intelligence based drug repurposing for diabetes epidemic.
    Mohanty S; Rashid MHA; Mohanty C; Swayamsiddha S
    Diabetes Metab Syndr; 2021; 15(4):102180. PubMed ID: 34186343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
    Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
    Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.